Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 5 art units • 5 examiners • 0 of 6 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Dr Kurt Wolff GmbH & Co. Kg maintains a portfolio in the Biotechnology & Pharmaceuticals sector with 6 pending office actions. These actions are distributed across 5 distinct examiners and 5 distinct art units, reflecting a broad technical footprint within the USPTO.
SCOTLAND, REBECCA LYNN serves as the busiest examiner for this portfolio, managing 2 pending office actions. The remaining pending actions are spread among the other distinct examiners. This distribution indicates that while prosecution is somewhat decentralized, a slight concentration exists under a single examiner.
Managing this many distinct art units requires a coordinated approach to ensure consistency across different pharmaceutical and biotech filings. The diversity of examiners suggests that the company must adapt to various individual styles and interpretations of patent law. Practitioners should monitor these distinct channels closely to maintain a unified strategy across the entire Biotechnology & Pharmaceuticals portfolio.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (50%) |
| Double-patenting + other | 1 (17%) |
| Multi-statute (no §101) | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SCOTLAND, REBECCA LYNN | 2 | 0.0% | +0.0% |
| ZHANG SPIERING, DONGXIU | 1 | 45.2% | +70.9% |
| MEYERS, ELIZABETH ANNE | 1 | 23.5% | +92.9% |
| CHANG, KYUNG SOOK | 1 | 60.4% | +40.9% |
| OLSEN, KAELEIGH ELIZABETH | 1 | 50.0% | +61.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18246405 | HYDROXYAPATITE COMPOSITION FOR TREATMENT AND/OR PREVENTION OF A VIRUS INFECTION | MEYERS, ELIZABETH ANNE | 85d |
| 17782566 | DEEP-LAYER REMINERALIZATION OF HYDROXYLAPATITE | SCOTLAND, REBECCA LYNN | 85d |
| 18247524 | Composition for Treating Hair and Scalp | SCOTLAND, REBECCA LYNN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17918532 | O/W EMULSION CONTAINING ETHANOL | OLSEN, KAELEIGH ELIZABETH | 80d overdue |
| 18246405 | HYDROXYAPATITE COMPOSITION FOR TREATMENT AND/OR PREVENTION OF A VIRUS INFECTION | MEYERS, ELIZABETH ANNE | 85d |
| 18247527 | Composition for Treating Hair and Skin | ZHANG SPIERING, DONGXIU | — |
| 17919955 | TREATMENT REGIMEN WITH MINOXIDIL AND CAFFEINE | CHANG, KYUNG SOOK | — |
| Art Unit | Apps |
|---|---|
| 1615 | 2 |
| 1616 | 1 |
| 1617 | 1 |
| 1613 | 1 |
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18247524 | Composition for Treating Hair and Scalp | SCOTLAND, REBECCA LYNN | 1615 | §102§103§112Other | Final Rejection | — | Pending | Oct 16, 2023 |
| 18247527 | Composition for Treating Hair and Skin | ZHANG SPIERING, DONGXIU | 1616 | §103Other | Non-Final OA | — | Pending | Mar 31, 2023 |
| 18246405 | HYDROXYAPATITE COMPOSITION FOR TREATMENT AND/OR PREVENTION OF A VIRUS INFECTION | MEYERS, ELIZABETH ANNE | 1617 | §103DP | Final Rejection | 85d | Pending | Mar 23, 2023 |
| 17919955 | TREATMENT REGIMEN WITH MINOXIDIL AND CAFFEINE | CHANG, KYUNG SOOK | 1613 | §103 | Final Rejection | — | Pending | Oct 19, 2022 |
| 17918532 | O/W EMULSION CONTAINING ETHANOL | OLSEN, KAELEIGH ELIZABETH | 1619 | §103 | Final Rejection | 80d overdue | Pending | Oct 12, 2022 |
| 17782566 | DEEP-LAYER REMINERALIZATION OF HYDROXYLAPATITE | SCOTLAND, REBECCA LYNN | 1615 | §103§112 | Final Rejection | 85d | Pending | Jun 03, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial